Trinity Biotech reported $3.38M in Interest Expense on Debt for its fiscal quarter ending in December of 2024.


Interest Expense On Debt Change Date
Abbott USD 50M 1000K Jun/2025
Bayer 495M 89M Jun/2025
Bio-Rad Laboratories USD 12.4M 400K Jun/2025
EDAP TMS EUR 0 20K Dec/2023
J&J USD 128M 9M Mar/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Siemens EUR 450M 200M Jun/2025
Thermo Fisher Scientific USD 404M 101M Jun/2025
Tosoh JPY 819M 98M Jun/2025
Trinity Biotech USD 3.38M 680K Dec/2024
Veracyte USD 0 0 Mar/2025